Methemoglobin formation after administration of hemoglobin conjugated to carboxylate dextran in guinea pigs. Attempts to prevent the oxidation of hemoglobin

Artificial Cells, Blood Substitutes, and Immobilization Biotechnology
B FaivreC Vigneron

Abstract

In 1990, McGown demonstrated in vitro a limitation of extracellular methemoglobin (metHb) formation by releasing and recycling of ascorbic acid by red blood cells. In order to investigate the autoxidation of free or modified hemoglobin in plasma and the possibility of reproducing McGown's phenomenon in vivo, we performed a 50% blood mass exchange in guinea-pigs with a 70 +/- 5 g/l dex-BTC-Hb solution (metHb < 5%). Methemoglobin was determined according to Evelyn-Malloy's method. We observed a clear but limited oxidation of plasmatic hemoglobin (MetHb approximately 30-40% at t = 12 hrs up to t = 24 hrs). A similar blood mass exchange was performed with the same hemoglobin solution which was previously totally oxidized into metHb. 40% of this methemoglobin was found to be reduced after 12 hrs. These results demonstrated a marked reducing activity by residual blood as shown by others. The addition of potentially protective compounds such as ascorbic acid (non enzymatic intraerythrocytar reduction pathway), methylene blue or riboflavin (enzymatic intraerythrocytar pathway), allowed a significant drop in the methemoglobin level. On the contrary, we didn't observe any reducing effect with reduced glutathione.

References

Aug 1, 1978·British Journal of Haematology·T MatsukiY Tani
Mar 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·F XuD E Hultquist
Dec 6, 1990·Biochimica Et Biophysica Acta·E L McGownA Zegna

❮ Previous
Next ❯

Citations

Jan 1, 1997·Free Radical Biology & Medicine·J Everse, N Hsia
Aug 1, 1996·Current Opinion in Structural Biology·K E SandersS Sligar
Dec 17, 2005·Antioxidants & Redox Signaling·Paul W Buehler, Abdu I Alayash
May 5, 2007·Expert Opinion on Biological Therapy·Abdu I AlayashPaul W Buehler
Jan 1, 1995·Artificial Cells, Blood Substitutes, and Immobilization Biotechnology·P MenuC Vigneron
Mar 4, 1999·Artificial Cells, Blood Substitutes, and Immobilization Biotechnology·A CaronC Vigneron
May 30, 2015·Artificial Cells, Nanomedicine, and Biotechnology·Timothy N Estep
Oct 9, 2007·Artificial Cells, Blood Substitutes, and Immobilization Biotechnology·Xue Ying HeQian Liu
Jun 9, 2004·Biochimica Et Biophysica Acta·Yiping JiaAbdu I Alayash
Nov 26, 1999·Pathology International·Y Sadahira, M Mori
Feb 10, 1999·The American Journal of Physiology·B Faivre-FiorinaC Vigneron

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of Laboratory and Clinical Medicine
J M PrzybockiR E Billings
Artificial Cells, Blood Substitutes, and Immobilization Biotechnology
K D Vandegriff, Y C Le Tellier
Artificial Cells, Blood Substitutes, and Immobilization Biotechnology
T Yang, K W Olsen
© 2021 Meta ULC. All rights reserved